NASDAQ:ARQQW Arqit Quantum (ARQQW) Stock Price, News & Analysis → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free ARQQW Stock Alerts $0.18 +0.02 (+12.77%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.15▼$0.2050-Day Range$0.13▼$0.2552-Week Range$0.04▼$0.50Volume19,848 shsAverage Volume9,413 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Arqit Quantum alerts: Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Arqit Quantum Stock (NASDAQ:ARQQW)Arqit Quantum Inc. provides cybersecurity services through satellite and terrestrial platforms in the United Kingdom. It offers QuantumCloud, a Platform as a Service that creates unbreakable software encryption keys. The company also provides maintenance and support, and professional services. Arqit Quantum Inc. is based in London, the United Kingdom.Read More ARQQW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARQQW Stock News HeadlinesMarch 16, 2024 | finance.yahoo.comARQQ Oct 2024 4.000 callMarch 16, 2024 | finance.yahoo.comARQQ Oct 2024 1.000 putMay 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.March 5, 2024 | finance.yahoo.comEquity Development Issues Research Note on ARQQ titled: "Growing acceptance of Arqit cloud-based services”February 13, 2024 | finance.yahoo.comArqit Quantum Inc.'s (NASDAQ:ARQQ) market cap increased by US$30m, insiders receive a 32% cutFebruary 5, 2024 | finance.yahoo.comArqit and Carahsoft Partner to Bring Symmetric Key Agreement Cybersecurity Product to the US Public SectorJanuary 10, 2024 | finance.yahoo.comArqit announces reseller agreement with PhalanxDecember 7, 2023 | finance.yahoo.comBabcock develops cutting-edge communications and control technology in partnership with ArqitMay 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.November 22, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Analog Devices (ADI), Emeren Group (SOL) and Arqit Quantum (ARQQ)November 22, 2023 | finance.yahoo.comArqit Quantum Inc. (NASDAQ:ARQQ) Q4 2023 Earnings Call TranscriptNovember 15, 2023 | finance.yahoo.comArqit Sets Fiscal Year 2023 Conference Call for Tuesday, November 21, 2023 at 11:00 a.m. ETSeptember 12, 2023 | finance.yahoo.comArqit Quantum Inc. Announces Closing of $16.2 Million Registered Direct OfferingSeptember 11, 2023 | uk.finance.yahoo.comArqit and Exclusive Networks announce US distribution partnershipSeptember 8, 2023 | marketwatch.comArqit Quantum Shares Hit 52-Week Low After Direct Offering PricesSeptember 7, 2023 | finance.yahoo.comArqit: New Product Launch and Business UpdateSeptember 6, 2023 | finance.yahoo.comArqit and SecureCloud+ partner to deliver cyber resilience using Symmetric Key AgreementSeptember 5, 2023 | marketwatch.comArqit Quantum Stock Up 19% on Juniper Networks' Collaboration for Network Connectivity SolutionSeptember 5, 2023 | finance.yahoo.comArqit launches the world's first integrated solution for quantum-safe VPN connectivity using Symmetric Key AgreementSee More Headlines Receive ARQQW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arqit Quantum and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Software - Infrastructure Sub-IndustryN/A Current SymbolNASDAQ:ARQQW CUSIPN/A CIK1859690 WebN/A Phone44-20-3917-0155FaxN/AEmployees147Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$640,000.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. David John Williams Esq. (Age 54)Founder, Executive Chairman & CEO Mr. David James Bestwick Esq. (Age 58)Co-Founder & CTO Dr. Geoffrey TaylorAdvisor & Co-FounderDr. Barry ChildeCo-Founder & CIOMr. Nicholas Pointon (Age 54)CFO & Executive Director Mr. Ben Olivier (Age 62)Managing Director of Operations Mr. Patrick Willcocks (Age 56)General Counsel & Corporate Secretary Mr. Paul Feenan (Age 50)Chief Revenue Officer Dr. Daniel Shiu (Age 54)Chief Cryptographer Mr. David WebbChief Software EngineerMore ExecutivesKey CompetitorsAEyeNASDAQ:LIDRWAirship AINASDAQ:AISPWAppTech PaymentsNASDAQ:APCXWArbe RoboticsNASDAQ:ARBEWAvePointNASDAQ:AVPTWView All Competitors ARQQW Stock Analysis - Frequently Asked Questions How have ARQQW shares performed in 2024? Arqit Quantum's stock was trading at $0.0875 at the beginning of the year. Since then, ARQQW shares have increased by 101.8% and is now trading at $0.1766. View the best growth stocks for 2024 here. Are investors shorting Arqit Quantum? Arqit Quantum saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,600 shares, an increase of 766.7% from the March 31st total of 300 shares. Based on an average daily trading volume, of 7,700 shares, the days-to-cover ratio is presently 0.3 days. View Arqit Quantum's Short Interest. Who are Arqit Quantum's major shareholders? Arqit Quantum's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of Arqit Quantum? Shares of ARQQW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ARQQW) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arqit Quantum Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
